The global synthetic biology market is projected to reach $61.6 billion by 2029

From GlobeNewswire: 2024-12-05 12:53:00

The global market for synthetic biology is expected to grow from $19.3 billion in 2024 to $61.6 billion by 2029, with a CAGR of 26.1%. The market covers products like oligonucleotides, synthetic genes, and enabling technologies such as DNA sequencing and gene editing, impacting industries like healthcare, consumer products, and agriculture.

Key drivers of the market include applications in various fields, increased R&D funding, reduced DNA sequencing costs, and continuous innovations like CRISPR-Cas9. The market is segmented by product type, end user, and region, with North America leading. Leading companies include Amyris, Ginkgo Bioworks, and Merck KGaA.

Interesting developments include a partnership between Amyris and Croda for sustainable squalene production, and Japan’s focus on biotechnology for a $837 billion bioeconomy by 2050. Market projections show the dominance of enabled products by 2029, with North America as the largest market share.

Related reports cover cell and gene therapy markets, viral vector technologies, and plasmid DNA analysis, offering insights into industry trends and forecasts up to 2028. For more information or to purchase reports, contact BCC Research for objective, unbiased market analysis and opportunities.



Read more at GlobeNewswire: Synthetic Biology Market Forecast: $61.6 Billion by 2029,